nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclopirox—Hair texture abnormal—Orlistat—type 2 diabetes mellitus	0.0905	0.0911	CcSEcCtD
Ciclopirox—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.0258	0.0259	CcSEcCtD
Ciclopirox—Burning sensation—Bromocriptine—type 2 diabetes mellitus	0.0219	0.0221	CcSEcCtD
Ciclopirox—Nail disorder—Gliclazide—type 2 diabetes mellitus	0.0193	0.0194	CcSEcCtD
Ciclopirox—Nail disorder—Orlistat—type 2 diabetes mellitus	0.0175	0.0176	CcSEcCtD
Ciclopirox—Nail disorder—Metformin—type 2 diabetes mellitus	0.0161	0.0162	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Bromocriptine—type 2 diabetes mellitus	0.0152	0.0153	CcSEcCtD
Ciclopirox—Eczema—Glipizide—type 2 diabetes mellitus	0.0146	0.0147	CcSEcCtD
Ciclopirox—Eczema—Sitagliptin—type 2 diabetes mellitus	0.0136	0.0137	CcSEcCtD
Ciclopirox—Erythema—Tolbutamide—type 2 diabetes mellitus	0.0131	0.0132	CcSEcCtD
Ciclopirox—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.0122	0.0123	CcSEcCtD
Ciclopirox—Erythema—Tolazamide—type 2 diabetes mellitus	0.0119	0.012	CcSEcCtD
Ciclopirox—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.0119	0.012	CcSEcCtD
Ciclopirox—Face oedema—Sitagliptin—type 2 diabetes mellitus	0.0118	0.0119	CcSEcCtD
Ciclopirox—Burning sensation—Ramipril—type 2 diabetes mellitus	0.0115	0.0115	CcSEcCtD
Ciclopirox—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.0115	0.0115	CcSEcCtD
Ciclopirox—Erythema—Acarbose—type 2 diabetes mellitus	0.0115	0.0115	CcSEcCtD
Ciclopirox—Eczema—Gliclazide—type 2 diabetes mellitus	0.0101	0.0102	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00997	0.01	CcSEcCtD
Ciclopirox—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.00992	0.00999	CcSEcCtD
Ciclopirox—Alopecia—Repaglinide—type 2 diabetes mellitus	0.0097	0.00977	CcSEcCtD
Ciclopirox—Erythema—Repaglinide—type 2 diabetes mellitus	0.00956	0.00962	CcSEcCtD
Ciclopirox—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00937	0.00944	CcSEcCtD
Ciclopirox—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00935	0.00942	CcSEcCtD
Ciclopirox—Ventricular tachycardia—Losartan—type 2 diabetes mellitus	0.00929	0.00935	CcSEcCtD
Ciclopirox—Eczema—Orlistat—type 2 diabetes mellitus	0.00917	0.00923	CcSEcCtD
Ciclopirox—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.00887	0.00893	CcSEcCtD
Ciclopirox—Dry skin—Gliclazide—type 2 diabetes mellitus	0.00832	0.00837	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00808	0.00814	CcSEcCtD
Ciclopirox—Erythema—Glipizide—type 2 diabetes mellitus	0.00791	0.00796	CcSEcCtD
Ciclopirox—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.00786	0.00791	CcSEcCtD
Ciclopirox—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.00763	0.00769	CcSEcCtD
Ciclopirox—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00758	0.00763	CcSEcCtD
Ciclopirox—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00756	0.00762	CcSEcCtD
Ciclopirox—Dry skin—Orlistat—type 2 diabetes mellitus	0.00755	0.0076	CcSEcCtD
Ciclopirox—Rash—Miglitol—type 2 diabetes mellitus	0.0075	0.00755	CcSEcCtD
Ciclopirox—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00749	0.00754	CcSEcCtD
Ciclopirox—Erythema—Glimepiride—type 2 diabetes mellitus	0.00738	0.00743	CcSEcCtD
Ciclopirox—Face oedema—Irbesartan—type 2 diabetes mellitus	0.00692	0.00696	CcSEcCtD
Ciclopirox—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00688	0.00693	CcSEcCtD
Ciclopirox—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00688	0.00693	CcSEcCtD
Ciclopirox—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.00676	0.0068	CcSEcCtD
Ciclopirox—Rash—Tolbutamide—type 2 diabetes mellitus	0.00674	0.00679	CcSEcCtD
Ciclopirox—Headache—Tolbutamide—type 2 diabetes mellitus	0.0067	0.00674	CcSEcCtD
Ciclopirox—Face oedema—Losartan—type 2 diabetes mellitus	0.00651	0.00655	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.0064	0.00645	CcSEcCtD
Ciclopirox—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00638	0.00642	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00622	0.00626	CcSEcCtD
Ciclopirox—Dry skin—Losartan—type 2 diabetes mellitus	0.00618	0.00622	CcSEcCtD
Ciclopirox—Alopecia—Glyburide—type 2 diabetes mellitus	0.00618	0.00622	CcSEcCtD
Ciclopirox—Rash—Tolazamide—type 2 diabetes mellitus	0.00613	0.00618	CcSEcCtD
Ciclopirox—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00613	0.00618	CcSEcCtD
Ciclopirox—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00609	0.00614	CcSEcCtD
Ciclopirox—Headache—Tolazamide—type 2 diabetes mellitus	0.00609	0.00614	CcSEcCtD
Ciclopirox—Erythema—Glyburide—type 2 diabetes mellitus	0.00609	0.00613	CcSEcCtD
Ciclopirox—Rash—Linagliptin—type 2 diabetes mellitus	0.00607	0.00611	CcSEcCtD
Ciclopirox—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00606	0.00611	CcSEcCtD
Ciclopirox—Headache—Linagliptin—type 2 diabetes mellitus	0.00603	0.00607	CcSEcCtD
Ciclopirox—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.006	0.00605	CcSEcCtD
Ciclopirox—Rash—Acarbose—type 2 diabetes mellitus	0.00589	0.00593	CcSEcCtD
Ciclopirox—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00589	0.00593	CcSEcCtD
Ciclopirox—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00583	0.00587	CcSEcCtD
Ciclopirox—Rash—Nateglinide—type 2 diabetes mellitus	0.00568	0.00572	CcSEcCtD
Ciclopirox—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00568	0.00572	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00563	0.00567	CcSEcCtD
Ciclopirox—Pain—Glipizide—type 2 diabetes mellitus	0.00552	0.00556	CcSEcCtD
Ciclopirox—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00552	0.00556	CcSEcCtD
Ciclopirox—Erythema—Gliclazide—type 2 diabetes mellitus	0.00546	0.0055	CcSEcCtD
Ciclopirox—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00528	0.00531	CcSEcCtD
Ciclopirox—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00522	0.00525	CcSEcCtD
Ciclopirox—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.00521	0.00525	CcSEcCtD
Ciclopirox—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00515	0.00518	CcSEcCtD
Ciclopirox—Pain—Sitagliptin—type 2 diabetes mellitus	0.00513	0.00517	CcSEcCtD
Ciclopirox—Alopecia—Valsartan—type 2 diabetes mellitus	0.0051	0.00513	CcSEcCtD
Ciclopirox—Alopecia—Orlistat—type 2 diabetes mellitus	0.00504	0.00507	CcSEcCtD
Ciclopirox—Rash—Repaglinide—type 2 diabetes mellitus	0.00492	0.00495	CcSEcCtD
Ciclopirox—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00491	0.00495	CcSEcCtD
Ciclopirox—Headache—Repaglinide—type 2 diabetes mellitus	0.00489	0.00492	CcSEcCtD
Ciclopirox—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00474	0.00478	CcSEcCtD
Ciclopirox—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00465	0.00468	CcSEcCtD
Ciclopirox—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00464	0.00468	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00462	0.00465	CcSEcCtD
Ciclopirox—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00462	0.00465	CcSEcCtD
Ciclopirox—Erythema—Metformin—type 2 diabetes mellitus	0.00457	0.0046	CcSEcCtD
Ciclopirox—Pruritus—Glipizide—type 2 diabetes mellitus	0.00457	0.0046	CcSEcCtD
Ciclopirox—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00448	0.00451	CcSEcCtD
Ciclopirox—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00433	0.00436	CcSEcCtD
Ciclopirox—Erythema—Irbesartan—type 2 diabetes mellitus	0.00431	0.00434	CcSEcCtD
Ciclopirox—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00426	0.00429	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00424	0.00427	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00419	0.00422	CcSEcCtD
Ciclopirox—Alopecia—Losartan—type 2 diabetes mellitus	0.00412	0.00415	CcSEcCtD
Ciclopirox—Rash—Glipizide—type 2 diabetes mellitus	0.00407	0.0041	CcSEcCtD
Ciclopirox—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00406	0.00409	CcSEcCtD
Ciclopirox—Erythema—Losartan—type 2 diabetes mellitus	0.00406	0.00409	CcSEcCtD
Ciclopirox—Headache—Glipizide—type 2 diabetes mellitus	0.00404	0.00407	CcSEcCtD
Ciclopirox—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00398	0.00401	CcSEcCtD
Ciclopirox—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00393	0.00396	CcSEcCtD
Ciclopirox—Headache—Pioglitazone—type 2 diabetes mellitus	0.00387	0.0039	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00387	0.00389	CcSEcCtD
Ciclopirox—Pain—Gliclazide—type 2 diabetes mellitus	0.00381	0.00384	CcSEcCtD
Ciclopirox—Rash—Glimepiride—type 2 diabetes mellitus	0.0038	0.00382	CcSEcCtD
Ciclopirox—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00379	0.00382	CcSEcCtD
Ciclopirox—Rash—Sitagliptin—type 2 diabetes mellitus	0.00378	0.00381	CcSEcCtD
Ciclopirox—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00378	0.00381	CcSEcCtD
Ciclopirox—Headache—Glimepiride—type 2 diabetes mellitus	0.00377	0.0038	CcSEcCtD
Ciclopirox—Headache—Sitagliptin—type 2 diabetes mellitus	0.00376	0.00379	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00365	0.00367	CcSEcCtD
Ciclopirox—Skin disorder—Metformin—type 2 diabetes mellitus	0.00362	0.00365	CcSEcCtD
Ciclopirox—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00361	0.00364	CcSEcCtD
Ciclopirox—Alopecia—Ramipril—type 2 diabetes mellitus	0.00353	0.00356	CcSEcCtD
Ciclopirox—Pruritus—Glyburide—type 2 diabetes mellitus	0.00351	0.00354	CcSEcCtD
Ciclopirox—Erythema—Ramipril—type 2 diabetes mellitus	0.00348	0.00351	CcSEcCtD
Ciclopirox—Pain—Orlistat—type 2 diabetes mellitus	0.00346	0.00349	CcSEcCtD
Ciclopirox—Rash—Bromocriptine—type 2 diabetes mellitus	0.00343	0.00345	CcSEcCtD
Ciclopirox—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00342	0.00345	CcSEcCtD
Ciclopirox—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00342	0.00344	CcSEcCtD
Ciclopirox—Headache—Bromocriptine—type 2 diabetes mellitus	0.0034	0.00343	CcSEcCtD
Ciclopirox—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00315	0.00318	CcSEcCtD
Ciclopirox—Rash—Glyburide—type 2 diabetes mellitus	0.00313	0.00315	CcSEcCtD
Ciclopirox—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00313	0.00315	CcSEcCtD
Ciclopirox—Headache—Glyburide—type 2 diabetes mellitus	0.00311	0.00313	CcSEcCtD
Ciclopirox—Pain—Irbesartan—type 2 diabetes mellitus	0.00301	0.00303	CcSEcCtD
Ciclopirox—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00294	0.00296	CcSEcCtD
Ciclopirox—Pruritus—Valsartan—type 2 diabetes mellitus	0.0029	0.00292	CcSEcCtD
Ciclopirox—Pruritus—Orlistat—type 2 diabetes mellitus	0.00286	0.00288	CcSEcCtD
Ciclopirox—Pain—Losartan—type 2 diabetes mellitus	0.00283	0.00285	CcSEcCtD
Ciclopirox—Rash—Gliclazide—type 2 diabetes mellitus	0.00281	0.00283	CcSEcCtD
Ciclopirox—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00281	0.00283	CcSEcCtD
Ciclopirox—Headache—Gliclazide—type 2 diabetes mellitus	0.00279	0.00281	CcSEcCtD
Ciclopirox—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00276	0.00278	CcSEcCtD
Ciclopirox—Pruritus—Metformin—type 2 diabetes mellitus	0.00264	0.00266	CcSEcCtD
Ciclopirox—Rash—Valsartan—type 2 diabetes mellitus	0.00258	0.0026	CcSEcCtD
Ciclopirox—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00258	0.0026	CcSEcCtD
Ciclopirox—Headache—Valsartan—type 2 diabetes mellitus	0.00257	0.00258	CcSEcCtD
Ciclopirox—Rash—Orlistat—type 2 diabetes mellitus	0.00255	0.00257	CcSEcCtD
Ciclopirox—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00255	0.00257	CcSEcCtD
Ciclopirox—Headache—Orlistat—type 2 diabetes mellitus	0.00254	0.00255	CcSEcCtD
Ciclopirox—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00249	0.00251	CcSEcCtD
Ciclopirox—Rash—Metformin—type 2 diabetes mellitus	0.00235	0.00237	CcSEcCtD
Ciclopirox—Dermatitis—Metformin—type 2 diabetes mellitus	0.00235	0.00237	CcSEcCtD
Ciclopirox—Pruritus—Losartan—type 2 diabetes mellitus	0.00234	0.00236	CcSEcCtD
Ciclopirox—Headache—Metformin—type 2 diabetes mellitus	0.00234	0.00235	CcSEcCtD
Ciclopirox—Rash—Irbesartan—type 2 diabetes mellitus	0.00222	0.00224	CcSEcCtD
Ciclopirox—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00222	0.00223	CcSEcCtD
Ciclopirox—Headache—Irbesartan—type 2 diabetes mellitus	0.00221	0.00222	CcSEcCtD
Ciclopirox—Rash—Losartan—type 2 diabetes mellitus	0.00209	0.0021	CcSEcCtD
Ciclopirox—Dermatitis—Losartan—type 2 diabetes mellitus	0.00209	0.0021	CcSEcCtD
Ciclopirox—Headache—Losartan—type 2 diabetes mellitus	0.00208	0.00209	CcSEcCtD
Ciclopirox—Pruritus—Ramipril—type 2 diabetes mellitus	0.00201	0.00202	CcSEcCtD
Ciclopirox—Rash—Ramipril—type 2 diabetes mellitus	0.00179	0.0018	CcSEcCtD
Ciclopirox—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00179	0.0018	CcSEcCtD
Ciclopirox—Headache—Ramipril—type 2 diabetes mellitus	0.00178	0.00179	CcSEcCtD
Ciclopirox—ATP1A1—Ion transport by P-type ATPases—PLN—type 2 diabetes mellitus	0.000958	0.152	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion transport by P-type ATPases—ATP2A3—type 2 diabetes mellitus	0.000746	0.118	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion transport by P-type ATPases—ATP2A2—type 2 diabetes mellitus	0.000536	0.0849	CbGpPWpGaD
Ciclopirox—ATP1A1—Preimplantation Embryo—HMGA1—type 2 diabetes mellitus	0.000386	0.0611	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.000363	0.0574	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion channel transport—PLN—type 2 diabetes mellitus	0.000332	0.0525	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.000258	0.0409	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000196	0.031	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000186	0.0294	CbGpPWpGaD
Ciclopirox—ATP1A1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.00018	0.0285	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000131	0.0207	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000126	0.02	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000126	0.02	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000115	0.0183	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000103	0.0163	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000103	0.0163	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	9.9e-05	0.0157	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	9.9e-05	0.0157	CbGpPWpGaD
Ciclopirox—ATP1A1—islet of Langerhans—type 2 diabetes mellitus	9.75e-05	0.152	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	9.73e-05	0.0154	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	8.99e-05	0.0142	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	8.42e-05	0.0133	CbGpPWpGaD
Ciclopirox—ATP1A1—retina—type 2 diabetes mellitus	8.34e-05	0.13	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	8.13e-05	0.0129	CbGpPWpGaD
Ciclopirox—ATP1A1—nephron tubule—type 2 diabetes mellitus	7.85e-05	0.123	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	7.8e-05	0.0123	CbGpPWpGaD
Ciclopirox—ATP1A1—cardiovascular system—type 2 diabetes mellitus	7.05e-05	0.11	CbGeAlD
Ciclopirox—ATP1A1—kidney—type 2 diabetes mellitus	6.9e-05	0.108	CbGeAlD
Ciclopirox—ATP1A1—pancreas—type 2 diabetes mellitus	6.85e-05	0.107	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	6.77e-05	0.0107	CbGpPWpGaD
Ciclopirox—ATP1A1—cortex of kidney—type 2 diabetes mellitus	6.72e-05	0.105	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	6.46e-05	0.0102	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	6.46e-05	0.0102	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	6.31e-05	0.00998	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	6.27e-05	0.00992	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.23e-05	0.00986	CbGpPWpGaD
Ciclopirox—ATP1A1—adipose tissue—type 2 diabetes mellitus	6.22e-05	0.0971	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	5.49e-05	0.00869	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.24e-05	0.00829	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.02e-05	0.00795	CbGpPWpGaD
Ciclopirox—ATP1A1—liver—type 2 diabetes mellitus	4.36e-05	0.0681	CbGeAlD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.33e-05	0.00685	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.31e-05	0.00682	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.27e-05	0.00676	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.13e-05	0.00653	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.86e-05	0.00611	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.48e-05	0.00551	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.27e-05	0.00517	CbGpPWpGaD
Ciclopirox—ATP1A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.59e-05	0.0041	CbGpPWpGaD
